EUSOMA认证乳腺中心质量指标的时间趋势(2006-2015)
该研究基于EUSOMA数据仓库,对2006-2015年间22个EUSOMA认证乳腺中心的46122例患者计算既定质量指标。结果显示,13项主要质量指标中达到最低标准的数量从2006年的8项增至2015年的全部13项,除腋窝清扫至少切除10枚淋巴结和雌激素受体阴性肿瘤(T>1cm或N+)接受辅助化疗两项外,其余指标均显著改善。
要点
- 2006年平均8/13项主要质量指标达最低标准,2015年全部13项达标。
- 除腋窝清扫至少切除10枚淋巴结和ER阴性肿瘤辅助化疗外,其余指标均显著改善。
- 理想目标达成数从2006年的2项增至2015年的7/13项。
核心结论
- EUSOMA的审计与质量指标监测模型在不同欧洲卫生系统中运行良好,过去十年间质量指标表现得到改善。
- 质量指标应定期评估和调整,因为指南随时间变化。
研究设计与样本
- 对2006-2015年间22个EUSOMA认证乳腺中心的46122例患者计算既定质量指标。
- 数据来自EUSOMA数据仓库,前瞻性收集匿名原发乳腺癌病例信息并每年传输至中央数据仓库。
- 认证中心须遵循EUSOMA乳腺中心指南并接受同行审计。
主要发现
- 全部中心平均,2006年13项主要EUSOMA质量指标中有8项达到最低标准,2015年全部达到。
- 除腋窝清扫至少切除10枚淋巴结和雌激素受体阴性肿瘤(T>1cm或N+)接受辅助化疗外,所有质量指标在该期间显著改善。
- 理想目标在2006年有2项质量指标达到,2015年13项中有7项达到。
关键数值与推荐
- 2006年达到最低标准的指标数:8/13;2015年:13/13。
- 2006年达到理想目标的指标数:2项;2015年:7/13项。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM OF THE STUDY: The European Society of Breast Cancer Specialists (EUSOMA) has fostered a voluntary certification process for breast centres to establish minimum standards and ensure specialist multidisciplinary care. Prospectively collected anonymous information on primary breast cancer cases diagnosed and treated in the units is transferred annually to a central EUSOMA data warehouse for continuous monitoring of quality indicators (QIs) to improve quality of care. Units have to comply with the EUSOMA Breast Centre guidelines and are audited by peers. The database was started in 2006 and includes over 110,000 cancers from breast centres located in Germany, Switzerland, Belgium, Austria, The Netherlands, Spain, Portugal and Italy. The aim of the present study is assessing time trends of QIs in EUSOMA-certified breast centres over the decade 2006-2015. MATERIALS AND METHODS: Previously defined QIs were calculated for 22 EUSOMA-certified breast centres (46122 patients) during 2006-2015. RESULTS: On the average of all units, the minimum standard of care was achieved in 8 of 13 main EUSOMA QIs in 2006 and in all in 2015. All QIs, except removal of at least 10 lymph nodes at axillary clearance and oestrogen receptor-negative tumours (T > 1 cm or N+) receiving adjuvant chemotherapy, improved significantly in this period. The desirable target was reached for two QIs in 2006 and for 7 of 13 QIs in 2015. CONCLUSION: The EUSOMA model of audit and monitoring QIs functions well in different European health systems and results in better performance of QIs over the last decade. QIs should be evaluated and adapted on a regular basis, as guidelines change over time.
引用
- van Dam PA, Tomatis M, Marotti L, et al. Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres. Eur J Cancer. 2017. PMID: 28881247. doi:10.1016/j.ejca.2017.07.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。